Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 17 MAY 2024

The Sky's The Limit – Yet More Section 301 Tariffs On China

Sheppard
Sheppard
Contributor
Sheppard

Sheppard

Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more...

View firm profile
Explore more from Sheppard

On May 14th at 5 am in DC, the White House released its decision on the new section 301 tariffs.

ChinaInternational Law
Curtis Dombek
Curtis Dombek
Author LinkedIn connections

On May 14th at 5 am in DC, the White House released its decision on the new section 301 tariffs. There is a 100% tariff on Chinese EVs effective this year (which is in addition to the usual 2.5% import duty on cars).

The tariff rate on Chinese lithium-ion EV batteries will increase from 7.5% to 25% in 2024, while the tariff rate on lithium-ion non-EV batteries will increase from 7.5% to 25% in 2026. The tariff rate on Chinese battery parts will increase from 7.5% to 25% in 2024.

The tariff rate on Chinese natural graphite and permanent magnets will increase from zero to 25% in 2026. The tariff rate for certain other critical minerals will increase from zero to 25% in 2024. The delay of the graphite tariff to 2026 fits with the need for U.S. industry to continue using Chinese graphite for some time until alternatives are developed. That reality was already reflected in the recently published IRS rules for tracing of EV battery minerals for IRA Section 30D

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

China’s Proposed Biopharma And AI Technology Export Controls: Pre-Export Registration Already Applies

China has proposed adding 40 technologies to its export control catalogue, targeting AI, biopharmaceuticals, and photovoltaics with new restrictions that distinguish platform ownership from product licensing. The amendments create a framework separating reusable capabilities from their applications, requiring companies to navigate complex registration requirements while structuring deals around deliverable rights.
ChinaInternational Law
Greenberg Traurig
Greenberg Traurig
Article

美国对伊朗8月24日“经济放逐”制裁行动行业性详解

关键词：伊朗、石油、航运、海运、数字资产、USDT、BTC、ETH、航材采购、供应链 美国最近一轮针对伊朗的制裁是2026年8月24日启动的“Operation Economic Outcast（“经济放逐”行动）”。对中国企业而言，这一轮美国对伊朗的制裁值得特别关注，因为OFAC的制裁重点已经不仅仅满足于“新增了哪些SDN”，而是美国正在明显অ
ChinaInternational Law
AnJie Broad Law Firm
AnJie Broad Law Firm
Article

Trump’s China Visit Will Likely Extend Trade Truce, While Points Of Friction Remain

President Trump's May 2026 state visit to China yielded agreements on trade boards, agricultural purchases, and tariff stability, but tensions persist over export controls and military company designations. As both nations pursue "strategic stability," multinational companies face increasing compliance conflicts from competing regulatory frameworks. Will the planned bilateral forums successfully navigate friction points in semiconductors, rare earths, and defense sectors?
ChinaInternational Law
Mayer Brown
Mayer Brown
Article

OCC Issues Examiner Framework For Banks’ Use Of Artificial Intelligence

The Office of the Comptroller of the Currency has released a new framework for evaluating banks' deployment of artificial intelligence and agentic AI systems in their business operations. This guidance establishes how examiners will assess AI through existing risk management disciplines rather than creating separate regulatory requirements, with review intensity scaled to each use case's potential consequences and level of human oversight.
United StatesFinance and Banking
Sheppard
Sheppard
Article

FDA Balances Peptide Policy With Enforcement Against Unlawful Peptide Sellers

Over the past year, industry has had a front row seat as the Food and Drug Administration (“FDA” or the “Agency”) decides just how much leeway it wants to afford the manufacture, marketing, and sale of peptide products, and just where it wants to draw the line. Despite the recent decision of FDA’s Pharmacy Compounding Advisory Committee (“PCAC”) to recommend a number of peptides for inclusion on the 503A bulks list process — a move that represents a potentially more permissive stance toward peptide regulation, at least in terms of what can and cannot be compounded under 503A...
United StatesFood, Drugs, Healthcare, Life Sciences
Sheppard
Sheppard
Article

Massachusetts Issues Guidance On Data Center Development Under Executive Order 658

Massachusetts Governor Maura Healey has issued Executive Order 658, establishing comprehensive permitting and regulatory standards for data centers exceeding 25 MW of peak electricity demand. The Order mandates community benefits agreements, clean energy procurement protocols, and coordination across multiple state agencies to ensure responsible development that protects ratepayers, communities, and the environment. This action positions Massachusetts alongside other states implementing stricter oversight o
United StatesEnergy and Natural Resources
Sheppard
Sheppard